Predict your next investment

NeurIMM Therapeutics company logo
HEALTHCARE | Biotechnology
neurimm.com

See what CB Insights has to offer

Investors Count

1

NeurIMM Therapeutics Funding, NeurIMM Therapeutics Valuation & NeurIMM Therapeutics Revenue

1 Fundings

NeurIMM Therapeutics's latest funding round was a Seed VC for on September 30, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/30/2018

Seed VC

$0.00B

((9.99x))

FY 1234

1

Date

9/30/2018

Round

Seed VC

Amount

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

Sources

1

NeurIMM Therapeutics Investors

1 Investors

NeurIMM Therapeutics has 1 investors. Seventure Partners invested in NeurIMM Therapeutics's Seed VC funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/30/2018

9/30/2018

1
Seed VC

Venture Capital

France

First funding

9/30/2018

Last Funding

9/30/2018

Investor

Rounds

1
Seed VC

Board Seats

Type

Venture Capital

Location

France

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.